CDC: Drug-Resistant Shigella Hit 8.5% of Cases in 2023

CDC: extensively drug-resistant Shigella rose from 0% in 2011-2015 to 8.5% of isolates in 2023, with no FDA-approved oral antibiotics left.

@sharedot

CDC: Drug-Resistant Shigella Hit 8.5% of Cases in 2023

By @sharedot · · 6 pages

  • Health
  • Shigella
  • Antibiotic Resistance

CDC: extensively drug-resistant Shigella rose from 0% in 2011-2015 to 8.5% of isolates in 2023, with no FDA-approved oral antibiotics left.

What the CDC surveillance found

The CDC analyzed 16,788 Shigella isolates submitted to PulseNet between Jan. 1, 2011 and Oct. 20, 2023.

Of those with resistance data, 510 — or 3% — were classified as extensively drug-resistant, resistant to five commonly used antibiotics: ampicillin, azithromycin, ceftriaxone, ciprofloxacin and trimethoprim-sulfamethoxazole.

The share jumped from 0% between 2011 and 2015 to 8.5% in 2023, and 415 cases — more than 84% of the total — were reported in 2022 and 2023 alone.

No approved oral antibiotics left

The reason this matters: there are no FDA-approved oral antibiotics specifically available to treat extensively drug-resistant Shigella infections, so doctors may need laboratory testing to determine which medications, if any, are likely to work.

Of the 258 patients with hospitalization information, 97 — 37.6% — were hospitalized, though no deaths were reported. The CDC noted the study likely underestimated the true number because not all Shigella-positive specimens were cultured or sequenced, and reporting varied by jurisdiction.

Sexual transmission is real — and resistance is concentrated there

USA Today reports that a UK study published in The Lancet Infectious Diseases in July found roughly 70% of sexually transmissible Shigella strains were resistant to at least one antibiotic by the end of the 2015-2020 study period, versus 40% of non-sexually transmitted strains and 49% of travel cases.

A Cambridge professor quoted in the study's press release said the disease has gone 'from being relatively treatable with off-the-shelf drugs to being close to untreatable' over the past decade.

Not an outbreak — but a serious public health issue

USA Today cautions that the 'surging' headlines mask steady numbers: 13,921 Americans had been diagnosed with shigellosis in 2026 as of Sept. 26, roughly on par with last year's 14,277 total. Still, experts call drug-resistant shigellosis a serious public health issue.

Prevention advice from the CDC includes thorough hand-washing with soap and running water, avoiding shared food preparation, not swimming while infected, and waiting at least two weeks after diarrhea symptoms stop before having sex.

People with weakened immune systems, including those living with HIV, face higher risk of severe illness.

Sources

  1. livenowfox.com › Sexually transmitted diarrhea cases soar in US as infections grow resistant to treatment
  2. usatoday.com › Is 'sexually transmitted diarrhea' a thing? Explaining Shigella illness

More on Health